COVID-19 Impact on Global Metastatic Malignant Melanoma Therapy Market Size, Status and Forecast 2020-2026

August 2020 | 97 pages | ID: C0B90A68BE8EEN
QYResearch

Abstracts

This report focuses on the global Metastatic Malignant Melanoma Therapy status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Metastatic Malignant Melanoma Therapy development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
The key players covered in this study

• Merck
• Pfizer
• Janssen Biotech
• Roche
• Navidea
• Novartis
• Bristol-Myers Squibb
• Enzon Pharmaceuticals
• Exelixis
• GlaxoSmithKline
• Ono Pharmaceutical
• Amgen

Market segment by Type, the product can be split into

• Immunotherapy
• Targeted Therapy
• Other

Market segment by Application, split into

• Hospital
• Medical Research Organization
• Other

Market segment by Regions/Countries, this report covers

• North America
• Europe
• China
• Japan
• Southeast Asia
• India
• Central & South America

The study objectives of this report are:

• To analyze global Metastatic Malignant Melanoma Therapy status, future forecast, growth opportunity, key market and key players.
• To present the Metastatic Malignant Melanoma Therapy development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
• To strategically profile the key players and comprehensively analyze their development plan and strategies.
• To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of Metastatic Malignant Melanoma Therapy are as follows:

• History Year: 2015-2019
• Base Year: 2019
• Estimated Year: 2020
• Forecast Year 2020 to 2026

For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Contents

1 REPORT OVERVIEW

1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Metastatic Malignant Melanoma Therapy Revenue
1.4 Market Analysis by Type
  1.4.1 Global Metastatic Malignant Melanoma Therapy Market Size Growth Rate by Type: 2020 VS 2026
  1.4.2 Immunotherapy
  1.4.3 Targeted Therapy
  1.4.4 Other
1.5 Market by Application
  1.5.1 Global Metastatic Malignant Melanoma Therapy Market Share by Application: 2020 VS 2026
  1.5.2 Hospital
  1.5.3 Medical Research Organization
  1.5.4 Other
1.6 Coronavirus Disease 2019 (Covid-19): Metastatic Malignant Melanoma Therapy Industry Impact
  1.6.1 How the Covid-19 is Affecting the Metastatic Malignant Melanoma Therapy Industry
    1.6.1.1 Metastatic Malignant Melanoma Therapy Business Impact Assessment - Covid-19
    1.6.1.2 Supply Chain Challenges
    1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
  1.6.2 Market Trends and Metastatic Malignant Melanoma Therapy Potential Opportunities in the COVID-19 Landscape
  1.6.3 Measures / Proposal against Covid-19
    1.6.3.1 Government Measures to Combat Covid-19 Impact
    1.6.3.2 Proposal for Metastatic Malignant Melanoma Therapy Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered

2 GLOBAL GROWTH TRENDS BY REGIONS

2.1 Metastatic Malignant Melanoma Therapy Market Perspective (2015-2026)
2.2 Metastatic Malignant Melanoma Therapy Growth Trends by Regions
  2.2.1 Metastatic Malignant Melanoma Therapy Market Size by Regions: 2015 VS 2020 VS 2026
  2.2.2 Metastatic Malignant Melanoma Therapy Historic Market Share by Regions (2015-2020)
  2.2.3 Metastatic Malignant Melanoma Therapy Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
  2.3.1 Market Top Trends
  2.3.2 Market Drivers
  2.3.3 Market Challenges
  2.3.4 Porter’s Five Forces Analysis
  2.3.5 Metastatic Malignant Melanoma Therapy Market Growth Strategy
  2.3.6 Primary Interviews with Key Metastatic Malignant Melanoma Therapy Players (Opinion Leaders)

3 COMPETITION LANDSCAPE BY KEY PLAYERS

3.1 Global Top Metastatic Malignant Melanoma Therapy Players by Market Size
  3.1.1 Global Top Metastatic Malignant Melanoma Therapy Players by Revenue (2015-2020)
  3.1.2 Global Metastatic Malignant Melanoma Therapy Revenue Market Share by Players (2015-2020)
  3.1.3 Global Metastatic Malignant Melanoma Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Metastatic Malignant Melanoma Therapy Market Concentration Ratio
  3.2.1 Global Metastatic Malignant Melanoma Therapy Market Concentration Ratio (CR5 and HHI)
  3.2.2 Global Top 10 and Top 5 Companies by Metastatic Malignant Melanoma Therapy Revenue in 2019
3.3 Metastatic Malignant Melanoma Therapy Key Players Head office and Area Served
3.4 Key Players Metastatic Malignant Melanoma Therapy Product Solution and Service
3.5 Date of Enter into Metastatic Malignant Melanoma Therapy Market
3.6 Mergers & Acquisitions, Expansion Plans

4 BREAKDOWN DATA BY TYPE (2015-2026)

4.1 Global Metastatic Malignant Melanoma Therapy Historic Market Size by Type (2015-2020)
4.2 Global Metastatic Malignant Melanoma Therapy Forecasted Market Size by Type (2021-2026)

5 METASTATIC MALIGNANT MELANOMA THERAPY BREAKDOWN DATA BY APPLICATION (2015-2026)

5.1 Global Metastatic Malignant Melanoma Therapy Market Size by Application (2015-2020)
5.2 Global Metastatic Malignant Melanoma Therapy Forecasted Market Size by Application (2021-2026)

6 NORTH AMERICA

6.1 North America Metastatic Malignant Melanoma Therapy Market Size (2015-2020)
6.2 Metastatic Malignant Melanoma Therapy Key Players in North America (2019-2020)
6.3 North America Metastatic Malignant Melanoma Therapy Market Size by Type (2015-2020)
6.4 North America Metastatic Malignant Melanoma Therapy Market Size by Application (2015-2020)

7 EUROPE

7.1 Europe Metastatic Malignant Melanoma Therapy Market Size (2015-2020)
7.2 Metastatic Malignant Melanoma Therapy Key Players in Europe (2019-2020)
7.3 Europe Metastatic Malignant Melanoma Therapy Market Size by Type (2015-2020)
7.4 Europe Metastatic Malignant Melanoma Therapy Market Size by Application (2015-2020)

8 CHINA

8.1 China Metastatic Malignant Melanoma Therapy Market Size (2015-2020)
8.2 Metastatic Malignant Melanoma Therapy Key Players in China (2019-2020)
8.3 China Metastatic Malignant Melanoma Therapy Market Size by Type (2015-2020)
8.4 China Metastatic Malignant Melanoma Therapy Market Size by Application (2015-2020)

9 JAPAN

9.1 Japan Metastatic Malignant Melanoma Therapy Market Size (2015-2020)
9.2 Metastatic Malignant Melanoma Therapy Key Players in Japan (2019-2020)
9.3 Japan Metastatic Malignant Melanoma Therapy Market Size by Type (2015-2020)
9.4 Japan Metastatic Malignant Melanoma Therapy Market Size by Application (2015-2020)

10 SOUTHEAST ASIA

10.1 Southeast Asia Metastatic Malignant Melanoma Therapy Market Size (2015-2020)
10.2 Metastatic Malignant Melanoma Therapy Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Metastatic Malignant Melanoma Therapy Market Size by Type (2015-2020)
10.4 Southeast Asia Metastatic Malignant Melanoma Therapy Market Size by Application (2015-2020)

11 INDIA

11.1 India Metastatic Malignant Melanoma Therapy Market Size (2015-2020)
11.2 Metastatic Malignant Melanoma Therapy Key Players in India (2019-2020)
11.3 India Metastatic Malignant Melanoma Therapy Market Size by Type (2015-2020)
11.4 India Metastatic Malignant Melanoma Therapy Market Size by Application (2015-2020)

12 CENTRAL & SOUTH AMERICA

12.1 Central & South America Metastatic Malignant Melanoma Therapy Market Size (2015-2020)
12.2 Metastatic Malignant Melanoma Therapy Key Players in Central & South America (2019-2020)
12.3 Central & South America Metastatic Malignant Melanoma Therapy Market Size by Type (2015-2020)
12.4 Central & South America Metastatic Malignant Melanoma Therapy Market Size by Application (2015-2020)

13 KEY PLAYERS PROFILES

13.1 Merck
  13.1.1 Merck Company Details
  13.1.2 Merck Business Overview and Its Total Revenue
  13.1.3 Merck Metastatic Malignant Melanoma Therapy Introduction
  13.1.4 Merck Revenue in Metastatic Malignant Melanoma Therapy Business (2015-2020))
  13.1.5 Merck Recent Development
13.2 Pfizer
  13.2.1 Pfizer Company Details
  13.2.2 Pfizer Business Overview and Its Total Revenue
  13.2.3 Pfizer Metastatic Malignant Melanoma Therapy Introduction
  13.2.4 Pfizer Revenue in Metastatic Malignant Melanoma Therapy Business (2015-2020)
  13.2.5 Pfizer Recent Development
13.3 Janssen Biotech
  13.3.1 Janssen Biotech Company Details
  13.3.2 Janssen Biotech Business Overview and Its Total Revenue
  13.3.3 Janssen Biotech Metastatic Malignant Melanoma Therapy Introduction
  13.3.4 Janssen Biotech Revenue in Metastatic Malignant Melanoma Therapy Business (2015-2020)
  13.3.5 Janssen Biotech Recent Development
13.4 Roche
  13.4.1 Roche Company Details
  13.4.2 Roche Business Overview and Its Total Revenue
  13.4.3 Roche Metastatic Malignant Melanoma Therapy Introduction
  13.4.4 Roche Revenue in Metastatic Malignant Melanoma Therapy Business (2015-2020)
  13.4.5 Roche Recent Development
13.5 Navidea
  13.5.1 Navidea Company Details
  13.5.2 Navidea Business Overview and Its Total Revenue
  13.5.3 Navidea Metastatic Malignant Melanoma Therapy Introduction
  13.5.4 Navidea Revenue in Metastatic Malignant Melanoma Therapy Business (2015-2020)
  13.5.5 Navidea Recent Development
13.6 Novartis
  13.6.1 Novartis Company Details
  13.6.2 Novartis Business Overview and Its Total Revenue
  13.6.3 Novartis Metastatic Malignant Melanoma Therapy Introduction
  13.6.4 Novartis Revenue in Metastatic Malignant Melanoma Therapy Business (2015-2020)
  13.6.5 Novartis Recent Development
13.7 Bristol-Myers Squibb
  13.7.1 Bristol-Myers Squibb Company Details
  13.7.2 Bristol-Myers Squibb Business Overview and Its Total Revenue
  13.7.3 Bristol-Myers Squibb Metastatic Malignant Melanoma Therapy Introduction
  13.7.4 Bristol-Myers Squibb Revenue in Metastatic Malignant Melanoma Therapy Business (2015-2020)
  13.7.5 Bristol-Myers Squibb Recent Development
13.8 Enzon Pharmaceuticals
  13.8.1 Enzon Pharmaceuticals Company Details
  13.8.2 Enzon Pharmaceuticals Business Overview and Its Total Revenue
  13.8.3 Enzon Pharmaceuticals Metastatic Malignant Melanoma Therapy Introduction
  13.8.4 Enzon Pharmaceuticals Revenue in Metastatic Malignant Melanoma Therapy Business (2015-2020)
  13.8.5 Enzon Pharmaceuticals Recent Development
13.9 Exelixis
  13.9.1 Exelixis Company Details
  13.9.2 Exelixis Business Overview and Its Total Revenue
  13.9.3 Exelixis Metastatic Malignant Melanoma Therapy Introduction
  13.9.4 Exelixis Revenue in Metastatic Malignant Melanoma Therapy Business (2015-2020)
  13.9.5 Exelixis Recent Development
13.10 GlaxoSmithKline
  13.10.1 GlaxoSmithKline Company Details
  13.10.2 GlaxoSmithKline Business Overview and Its Total Revenue
  13.10.3 GlaxoSmithKline Metastatic Malignant Melanoma Therapy Introduction
  13.10.4 GlaxoSmithKline Revenue in Metastatic Malignant Melanoma Therapy Business (2015-2020)
  13.10.5 GlaxoSmithKline Recent Development
13.11 Ono Pharmaceutical
  10.11.1 Ono Pharmaceutical Company Details
  10.11.2 Ono Pharmaceutical Business Overview and Its Total Revenue
  10.11.3 Ono Pharmaceutical Metastatic Malignant Melanoma Therapy Introduction
  10.11.4 Ono Pharmaceutical Revenue in Metastatic Malignant Melanoma Therapy Business (2015-2020)
  10.11.5 Ono Pharmaceutical Recent Development
13.12 Amgen
  10.12.1 Amgen Company Details
  10.12.2 Amgen Business Overview and Its Total Revenue
  10.12.3 Amgen Metastatic Malignant Melanoma Therapy Introduction
  10.12.4 Amgen Revenue in Metastatic Malignant Melanoma Therapy Business (2015-2020)
  10.12.5 Amgen Recent Development

14 ANALYST'S VIEWPOINTS/CONCLUSIONS

15 APPENDIX

15.1 Research Methodology
  15.1.1 Methodology/Research Approach
  15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List Of Tables

LIST OF TABLES

Table 1. Metastatic Malignant Melanoma Therapy Key Market Segments
Table 2. Key Players Covered: Ranking by Metastatic Malignant Melanoma Therapy Revenue
Table 3. Ranking of Global Top Metastatic Malignant Melanoma Therapy Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Metastatic Malignant Melanoma Therapy Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Immunotherapy
Table 6. Key Players of Targeted Therapy
Table 7. Key Players of Other
Table 8. COVID-19 Impact Global Market: (Four Metastatic Malignant Melanoma Therapy Market Size Forecast Scenarios)
Table 9. Opportunities and Trends for Metastatic Malignant Melanoma Therapy Players in the COVID-19 Landscape
Table 10. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 11. Key Regions/Countries Measures against Covid-19 Impact
Table 12. Proposal for Metastatic Malignant Melanoma Therapy Players to Combat Covid-19 Impact
Table 13. Global Metastatic Malignant Melanoma Therapy Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 14. Global Metastatic Malignant Melanoma Therapy Market Size by Regions (US$ Million): 2020 VS 2026
Table 15. Global Metastatic Malignant Melanoma Therapy Market Size by Regions (2015-2020) (US$ Million)
Table 16. Global Metastatic Malignant Melanoma Therapy Market Share by Regions (2015-2020)
Table 17. Global Metastatic Malignant Melanoma Therapy Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 18. Global Metastatic Malignant Melanoma Therapy Market Share by Regions (2021-2026)
Table 19. Market Top Trends
Table 20. Key Drivers: Impact Analysis
Table 21. Key Challenges
Table 22. Metastatic Malignant Melanoma Therapy Market Growth Strategy
Table 23. Main Points Interviewed from Key Metastatic Malignant Melanoma Therapy Players
Table 24. Global Metastatic Malignant Melanoma Therapy Revenue by Players (2015-2020) (Million US$)
Table 25. Global Metastatic Malignant Melanoma Therapy Market Share by Players (2015-2020)
Table 26. Global Top Metastatic Malignant Melanoma Therapy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Metastatic Malignant Melanoma Therapy as of 2019)
Table 27. Global Metastatic Malignant Melanoma Therapy by Players Market Concentration Ratio (CR5 and HHI)
Table 28. Key Players Headquarters and Area Served
Table 29. Key Players Metastatic Malignant Melanoma Therapy Product Solution and Service
Table 30. Date of Enter into Metastatic Malignant Melanoma Therapy Market
Table 31. Mergers & Acquisitions, Expansion Plans
Table 32. Global Metastatic Malignant Melanoma Therapy Market Size by Type (2015-2020) (Million US$)
Table 33. Global Metastatic Malignant Melanoma Therapy Market Size Share by Type (2015-2020)
Table 34. Global Metastatic Malignant Melanoma Therapy Revenue Market Share by Type (2021-2026)
Table 35. Global Metastatic Malignant Melanoma Therapy Market Size Share by Application (2015-2020)
Table 36. Global Metastatic Malignant Melanoma Therapy Market Size by Application (2015-2020) (Million US$)
Table 37. Global Metastatic Malignant Melanoma Therapy Market Size Share by Application (2021-2026)
Table 38. North America Key Players Metastatic Malignant Melanoma Therapy Revenue (2019-2020) (Million US$)
Table 39. North America Key Players Metastatic Malignant Melanoma Therapy Market Share (2019-2020)
Table 40. North America Metastatic Malignant Melanoma Therapy Market Size by Type (2015-2020) (Million US$)
Table 41. North America Metastatic Malignant Melanoma Therapy Market Share by Type (2015-2020)
Table 42. North America Metastatic Malignant Melanoma Therapy Market Size by Application (2015-2020) (Million US$)
Table 43. North America Metastatic Malignant Melanoma Therapy Market Share by Application (2015-2020)
Table 44. Europe Key Players Metastatic Malignant Melanoma Therapy Revenue (2019-2020) (Million US$)
Table 45. Europe Key Players Metastatic Malignant Melanoma Therapy Market Share (2019-2020)
Table 46. Europe Metastatic Malignant Melanoma Therapy Market Size by Type (2015-2020) (Million US$)
Table 47. Europe Metastatic Malignant Melanoma Therapy Market Share by Type (2015-2020)
Table 48. Europe Metastatic Malignant Melanoma Therapy Market Size by Application (2015-2020) (Million US$)
Table 49. Europe Metastatic Malignant Melanoma Therapy Market Share by Application (2015-2020)
Table 50. China Key Players Metastatic Malignant Melanoma Therapy Revenue (2019-2020) (Million US$)
Table 51. China Key Players Metastatic Malignant Melanoma Therapy Market Share (2019-2020)
Table 52. China Metastatic Malignant Melanoma Therapy Market Size by Type (2015-2020) (Million US$)
Table 53. China Metastatic Malignant Melanoma Therapy Market Share by Type (2015-2020)
Table 54. China Metastatic Malignant Melanoma Therapy Market Size by Application (2015-2020) (Million US$)
Table 55. China Metastatic Malignant Melanoma Therapy Market Share by Application (2015-2020)
Table 56. Japan Key Players Metastatic Malignant Melanoma Therapy Revenue (2019-2020) (Million US$)
Table 57. Japan Key Players Metastatic Malignant Melanoma Therapy Market Share (2019-2020)
Table 58. Japan Metastatic Malignant Melanoma Therapy Market Size by Type (2015-2020) (Million US$)
Table 59. Japan Metastatic Malignant Melanoma Therapy Market Share by Type (2015-2020)
Table 60. Japan Metastatic Malignant Melanoma Therapy Market Size by Application (2015-2020) (Million US$)
Table 61. Japan Metastatic Malignant Melanoma Therapy Market Share by Application (2015-2020)
Table 62. Southeast Asia Key Players Metastatic Malignant Melanoma Therapy Revenue (2019-2020) (Million US$)
Table 63. Southeast Asia Key Players Metastatic Malignant Melanoma Therapy Market Share (2019-2020)
Table 64. Southeast Asia Metastatic Malignant Melanoma Therapy Market Size by Type (2015-2020) (Million US$)
Table 65. Southeast Asia Metastatic Malignant Melanoma Therapy Market Share by Type (2015-2020)
Table 66. Southeast Asia Metastatic Malignant Melanoma Therapy Market Size by Application (2015-2020) (Million US$)
Table 67. Southeast Asia Metastatic Malignant Melanoma Therapy Market Share by Application (2015-2020)
Table 68. India Key Players Metastatic Malignant Melanoma Therapy Revenue (2019-2020) (Million US$)
Table 69. India Key Players Metastatic Malignant Melanoma Therapy Market Share (2019-2020)
Table 70. India Metastatic Malignant Melanoma Therapy Market Size by Type (2015-2020) (Million US$)
Table 71. India Metastatic Malignant Melanoma Therapy Market Share by Type (2015-2020)
Table 72. India Metastatic Malignant Melanoma Therapy Market Size by Application (2015-2020) (Million US$)
Table 73. India Metastatic Malignant Melanoma Therapy Market Share by Application (2015-2020)
Table 74. Central & South America Key Players Metastatic Malignant Melanoma Therapy Revenue (2019-2020) (Million US$)
Table 75. Central & South America Key Players Metastatic Malignant Melanoma Therapy Market Share (2019-2020)
Table 76. Central & South America Metastatic Malignant Melanoma Therapy Market Size by Type (2015-2020) (Million US$)
Table 77. Central & South America Metastatic Malignant Melanoma Therapy Market Share by Type (2015-2020)
Table 78. Central & South America Metastatic Malignant Melanoma Therapy Market Size by Application (2015-2020) (Million US$)
Table 79. Central & South America Metastatic Malignant Melanoma Therapy Market Share by Application (2015-2020)
Table 80. Merck Company Details
Table 81. Merck Business Overview
Table 82. Merck Product
Table 83. Merck Revenue in Metastatic Malignant Melanoma Therapy Business (2015-2020) (Million US$)
Table 84. Merck Recent Development
Table 85. Pfizer Company Details
Table 86. Pfizer Business Overview
Table 87. Pfizer Product
Table 88. Pfizer Revenue in Metastatic Malignant Melanoma Therapy Business (2015-2020) (Million US$)
Table 89. Pfizer Recent Development
Table 90. Janssen Biotech Company Details
Table 91. Janssen Biotech Business Overview
Table 92. Janssen Biotech Product
Table 93. Janssen Biotech Revenue in Metastatic Malignant Melanoma Therapy Business (2015-2020) (Million US$)
Table 94. Janssen Biotech Recent Development
Table 95. Roche Company Details
Table 96. Roche Business Overview
Table 97. Roche Product
Table 98. Roche Revenue in Metastatic Malignant Melanoma Therapy Business (2015-2020) (Million US$)
Table 99. Roche Recent Development
Table 100. Navidea Company Details
Table 101. Navidea Business Overview
Table 102. Navidea Product
Table 103. Navidea Revenue in Metastatic Malignant Melanoma Therapy Business (2015-2020) (Million US$)
Table 104. Navidea Recent Development
Table 105. Novartis Company Details
Table 106. Novartis Business Overview
Table 107. Novartis Product
Table 108. Novartis Revenue in Metastatic Malignant Melanoma Therapy Business (2015-2020) (Million US$)
Table 109. Novartis Recent Development
Table 110. Bristol-Myers Squibb Company Details
Table 111. Bristol-Myers Squibb Business Overview
Table 112. Bristol-Myers Squibb Product
Table 113. Bristol-Myers Squibb Revenue in Metastatic Malignant Melanoma Therapy Business (2015-2020) (Million US$)
Table 114. Bristol-Myers Squibb Recent Development
Table 115. Enzon Pharmaceuticals Business Overview
Table 116. Enzon Pharmaceuticals Product
Table 117. Enzon Pharmaceuticals Company Details
Table 118. Enzon Pharmaceuticals Revenue in Metastatic Malignant Melanoma Therapy Business (2015-2020) (Million US$)
Table 119. Enzon Pharmaceuticals Recent Development
Table 120. Exelixis Company Details
Table 121. Exelixis Business Overview
Table 122. Exelixis Product
Table 123. Exelixis Revenue in Metastatic Malignant Melanoma Therapy Business (2015-2020) (Million US$)
Table 124. Exelixis Recent Development
Table 125. GlaxoSmithKline Company Details
Table 126. GlaxoSmithKline Business Overview
Table 127. GlaxoSmithKline Product
Table 128. GlaxoSmithKline Revenue in Metastatic Malignant Melanoma Therapy Business (2015-2020) (Million US$)
Table 129. GlaxoSmithKline Recent Development
Table 130. Ono Pharmaceutical Company Details
Table 131. Ono Pharmaceutical Business Overview
Table 132. Ono Pharmaceutical Product
Table 133. Ono Pharmaceutical Revenue in Metastatic Malignant Melanoma Therapy Business (2015-2020) (Million US$)
Table 134. Ono Pharmaceutical Recent Development
Table 135. Amgen Company Details
Table 136. Amgen Business Overview
Table 137. Amgen Product
Table 138. Amgen Revenue in Metastatic Malignant Melanoma Therapy Business (2015-2020) (Million US$)
Table 139. Amgen Recent Development
Table 140. Research Programs/Design for This Report
Table 141. Key Data Information from Secondary Sources
Table 142. Key Data Information from Primary Sources

List Of Figures

LIST OF FIGURES

Figure 1. Global Metastatic Malignant Melanoma Therapy Market Share by Type: 2020 VS 2026
Figure 2. Immunotherapy Features
Figure 3. Targeted Therapy Features
Figure 4. Other Features
Figure 5. Global Metastatic Malignant Melanoma Therapy Market Share by Application: 2020 VS 2026
Figure 6. Hospital Case Studies
Figure 7. Medical Research Organization Case Studies
Figure 8. Other Case Studies
Figure 9. Metastatic Malignant Melanoma Therapy Report Years Considered
Figure 10. Global Metastatic Malignant Melanoma Therapy Market Size YoY Growth 2015-2026 (US$ Million)
Figure 11. Global Metastatic Malignant Melanoma Therapy Market Share by Regions: 2020 VS 2026
Figure 12. Global Metastatic Malignant Melanoma Therapy Market Share by Regions (2021-2026)
Figure 13. Porter's Five Forces Analysis
Figure 14. Global Metastatic Malignant Melanoma Therapy Market Share by Players in 2019
Figure 15. Global Top Metastatic Malignant Melanoma Therapy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Metastatic Malignant Melanoma Therapy as of 2019
Figure 16. The Top 10 and 5 Players Market Share by Metastatic Malignant Melanoma Therapy Revenue in 2019
Figure 17. North America Metastatic Malignant Melanoma Therapy Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. Europe Metastatic Malignant Melanoma Therapy Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. China Metastatic Malignant Melanoma Therapy Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Japan Metastatic Malignant Melanoma Therapy Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Southeast Asia Metastatic Malignant Melanoma Therapy Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. India Metastatic Malignant Melanoma Therapy Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Central & South America Metastatic Malignant Melanoma Therapy Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Merck Total Revenue (US$ Million): 2019 Compared with 2018
Figure 25. Merck Revenue Growth Rate in Metastatic Malignant Melanoma Therapy Business (2015-2020)
Figure 26. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 27. Pfizer Revenue Growth Rate in Metastatic Malignant Melanoma Therapy Business (2015-2020)
Figure 28. Janssen Biotech Total Revenue (US$ Million): 2019 Compared with 2018
Figure 29. Janssen Biotech Revenue Growth Rate in Metastatic Malignant Melanoma Therapy Business (2015-2020)
Figure 30. Roche Total Revenue (US$ Million): 2019 Compared with 2018
Figure 31. Roche Revenue Growth Rate in Metastatic Malignant Melanoma Therapy Business (2015-2020)
Figure 32. Navidea Total Revenue (US$ Million): 2019 Compared with 2018
Figure 33. Navidea Revenue Growth Rate in Metastatic Malignant Melanoma Therapy Business (2015-2020)
Figure 34. Novartis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 35. Novartis Revenue Growth Rate in Metastatic Malignant Melanoma Therapy Business (2015-2020)
Figure 36. Bristol-Myers Squibb Total Revenue (US$ Million): 2019 Compared with 2018
Figure 37. Bristol-Myers Squibb Revenue Growth Rate in Metastatic Malignant Melanoma Therapy Business (2015-2020)
Figure 38. Enzon Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 39. Enzon Pharmaceuticals Revenue Growth Rate in Metastatic Malignant Melanoma Therapy Business (2015-2020)
Figure 40. Exelixis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 41. Exelixis Revenue Growth Rate in Metastatic Malignant Melanoma Therapy Business (2015-2020)
Figure 42. GlaxoSmithKline Total Revenue (US$ Million): 2019 Compared with 2018
Figure 43. GlaxoSmithKline Revenue Growth Rate in Metastatic Malignant Melanoma Therapy Business (2015-2020)
Figure 44. Ono Pharmaceutical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 45. Ono Pharmaceutical Revenue Growth Rate in Metastatic Malignant Melanoma Therapy Business (2015-2020)
Figure 46. Amgen Total Revenue (US$ Million): 2019 Compared with 2018
Figure 47. Amgen Revenue Growth Rate in Metastatic Malignant Melanoma Therapy Business (2015-2020)
Figure 48. Bottom-up and Top-down Approaches for This Report
Figure 49. Data Triangulation
Figure 50. Key Executives Interviewed